222 related articles for article (PubMed ID: 31372898)
1. The emerging role of substance P/neurokinin-1 receptor signaling pathways in growth and development of tumor cells.
Javid H; Mohammadi F; Zahiri E; Hashemy SI
J Physiol Biochem; 2019 Nov; 75(4):415-421. PubMed ID: 31372898
[TBL] [Abstract][Full Text] [Related]
2. New insight into the role of substance P/neurokinin-1 receptor system in breast cancer progression and its crosstalk with microRNAs.
Ebrahimi S; Javid H; Alaei A; Hashemy SI
Clin Genet; 2020 Oct; 98(4):322-330. PubMed ID: 32266968
[TBL] [Abstract][Full Text] [Related]
3. A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage.
Esteban F; Muñoz M; González-Moles MA; Rosso M
Cancer Metastasis Rev; 2006 Mar; 25(1):137-45. PubMed ID: 16680578
[TBL] [Abstract][Full Text] [Related]
4. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
5. Substance P and the Neurokinin-1 Receptor: The New CRF.
Schank JR; Heilig M
Int Rev Neurobiol; 2017; 136():151-175. PubMed ID: 29056150
[TBL] [Abstract][Full Text] [Related]
6. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
7. Extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase, through nuclear factor-kappaB and activator protein-1, contribute to caerulein-induced expression of substance P and neurokinin-1 receptors in pancreatic acinar cells.
Koh YH; Tamizhselvi R; Bhatia M
J Pharmacol Exp Ther; 2010 Mar; 332(3):940-8. PubMed ID: 20007404
[TBL] [Abstract][Full Text] [Related]
8. Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).
Chernova I; Lai JP; Li H; Schwartz L; Tuluc F; Korchak HM; Douglas SD; Kilpatrick LE
J Leukoc Biol; 2009 Jan; 85(1):154-64. PubMed ID: 18835883
[TBL] [Abstract][Full Text] [Related]
9. Substance P and Neurokinin 1 Receptor in Chronic Inflammation and Cancer of the Head and Neck: A Review of the Literature.
Esteban F; Ramos-García P; Muñoz M; González-Moles MÁ
Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010633
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Blocking Neurokinin-1 Receptor by Aprepitant on the Inflammatory and Apoptosis Pathways in Human Ovarian Cancer Cells.
AlAlikhan A; Ghahremanloo A; Javid H; Ebrahimi S; Hashemy SI
Cell Biochem Biophys; 2022 Dec; 80(4):819-827. PubMed ID: 36197642
[TBL] [Abstract][Full Text] [Related]
11. Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells.
Garnier A; Vykoukal J; Hubertus J; Alt E; von Schweinitz D; Kappler R; Berger M; Ilmer M
Int J Oncol; 2015 Jul; 47(1):151-60. PubMed ID: 25998227
[TBL] [Abstract][Full Text] [Related]
12. Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.
Zhou Y; Zhao L; Xiong T; Chen X; Zhang Y; Yu M; Yang J; Yao Z
Breast Cancer Res Treat; 2013 Jul; 140(1):49-61. PubMed ID: 23807418
[TBL] [Abstract][Full Text] [Related]
13. Expression of different neurokinin-1 receptor (NK1R) isoforms in glioblastoma multiforme: potential implications for targeted therapy.
Cordier D; Gerber A; Kluba C; Bauman A; Hutter G; Mindt TL; Mariani L
Cancer Biother Radiopharm; 2014 Jun; 29(5):221-6. PubMed ID: 24552486
[TBL] [Abstract][Full Text] [Related]
14. Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.
Douglas SD; Leeman SE
Ann N Y Acad Sci; 2011 Jan; 1217():83-95. PubMed ID: 21091716
[TBL] [Abstract][Full Text] [Related]
15. Do Substance P and Neurokinin A Play Important Roles in the Control of LH Secretion in Ewes?
Fergani C; Mazzella L; Coolen LM; McCosh RB; Hardy SL; Newcomb N; Grachev P; Lehman MN; Goodman RL
Endocrinology; 2016 Dec; 157(12):4829-4841. PubMed ID: 27704950
[TBL] [Abstract][Full Text] [Related]
16. The effect of CP96,345 on the expression of tachykinins and neurokinin receptors in acute pancreatitis.
Lau HY; Bhatia M
J Pathol; 2006 Feb; 208(3):364-71. PubMed ID: 16369913
[TBL] [Abstract][Full Text] [Related]
17. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
[TBL] [Abstract][Full Text] [Related]
18. Role of substance P in the cardiovascular system.
Mistrova E; Kruzliak P; Chottova Dvorakova M
Neuropeptides; 2016 Aug; 58():41-51. PubMed ID: 26706184
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in colorectal cancer.
Lorestani S; Ghahremanloo A; Jangjoo A; Abedi M; Hashemy SI
Mol Biol Rep; 2020 May; 47(5):3469-3474. PubMed ID: 32277443
[TBL] [Abstract][Full Text] [Related]
20. Neurokinin-1 receptor activation in the Bötzinger complex evokes bradypnea and is involved in mediating the Hering-Breuer reflex.
Fong AY; Potts JT
Adv Exp Med Biol; 2008; 605():366-70. PubMed ID: 18085301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]